Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)
Clinical trial NCT00328601 · COMPLETED
Trial details
- NCT number
- NCT00328601
- Sponsor
- MEDA Pharma GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.